Showing results (161-170 of 208) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2025
Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer: AMBER Part 2BDiwakar Davar, Zeynep Eroglu, Mohammed Milhem, et al.
British Journal of Cancer|May 29, 2021
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomasBrian Schulte, Nisha Mohindra, Mohammed Milhem, et al.
Journal for Immunotherapy of Cancer|March 18, 2025
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)Gliceida M Galarza Fortuna, Daniel Grass, Benjamin L Maughan, et al.
The Oncologist|March 11, 2022
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate CancerMeredith N Freeman, Albert Jang, Jason Zhu, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2021
An open-label single-arm phase II study of regorafenib for the treatment of angiosarcomaMark Agulnik, Brian Schulte, Steven Robinson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2019
Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K-mutant advanced or metastatic melanomaCaroline Robert, Keith Flaherty, Paul Nathan, et al.
Research Square|July 3, 2023
Response to high dose ipilimumab plus temozolomide after progression on standard or low dose ipilimumab in advanced melanoma: a retrospective analysisJulie Williamson, Muhammad Zaki Hidayatullah Fadlullah, Magdalena Kovacsovics-Bankowski, et al.
The Prostate|April 1, 2024
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive settingGeorges Gebrael, Chadi Hage Chehade, Nicolas Sayegh, et al.
JCO Oncology Practice|June 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO GuidelineChristina M Lockwood, Hans J Messersmith, Annette S Kim, et al.
Clinical Proteomics|April 18, 2025
Circulatory prostate cancer proteome landscapes and prognostic biomarkers in metastatic castrate resistant prostate cancerHyejung Lee, Jincheng Shen, Muhammad Zaki Fadlullah, et al.
Pageof 21